AsianScientist (Feb. 29, 2012) – Agilent Technologies Inc. and sequencing company BGI today announced a collaborative effort to develop new methods for next-generation genome-wide association studies.
“Together with Agilent’s expertise, we can create more precise and accurate technology that can be deployed in large-scale research to better understand complex diseases, which may have differences between ethnicities,” said Hui Jiang, associate director of the Science and Technology Department at BGI.
As part of this collaboration, BGI will have access to Agilent’s comprehensive portfolio of solutions for genomics research and next-generation sequencing tools, including Agilent’s SureSelect target-enrichment system and 2100 bioanalyzers.
Additionally, Agilent will grant BGI early access to newly developed tools for the sequencing space.
BGI and Agilent have been working closely together over the years. Previously, BGI used Agilent’s technologies to streamline and enhance the throughput of BGI’s next-generation sequencing workflow. In China, BGI became the country’s first certified SureSelect XT service provider.
——
Source: Agilent Technologies Inc.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
